Drug intelligence / Profile preview

Sepia

Development stage: Phase 3
Administration: Oral, Sublingual

Overview

Sepia is a homeopathic preparation derived from the ink of the common cuttlefish, *Sepia officinalis*. In homeopathy, it is used to treat a variety of conditions based on the principle of 'like cures like', where highly diluted substances are believed to stimulate the body's healing response. Clinical investigations have explored its potential in alleviating symptoms of premenstrual syndrome and in the treatment of dermatophytosis, specifically tinea corporis and tinea cruris.

Beyond the preview

Go deeper on Sepia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sepia.

Explore the full profile